Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Manufacturing (cGMP) deviations

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards.

1,754 FDA drug recalls with this cause, newest first.

This category covers departures from current Good Manufacturing Practice during production. It is FDA's broadest label, used when a facility's own process control failed somewhere along the line even if no single ingredient was proven unsafe on its own. Where the report names a specific consequence - a temperature excursion, a contaminant, a potency problem - we file the recall under that more specific cause instead; what remains here is the genuinely general case.

Class II · Moderate risk

Hydroxocobalamin B12

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0080-30 D-0826-2022
Class II · Moderate risk

Ultratest

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0058-10 D-0825-2022
Class II · Moderate risk

Testosterone Cypionate 200 mg/mL

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0055-10 D-0824-2022
Class II · Moderate risk

Testosterone Cypionate 200 mg/mL

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0054-10 D-0823-2022
Class II · Moderate risk

Phenylephrine 1 mg/mL

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0021-05 D-0822-2022
Class II · Moderate risk

Formula F2

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0002-10 D-0821-2022
Class II · Moderate risk

T-50

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0022-10 D-0820-2022
Class II · Moderate risk

Pge-3

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0030-10 D-0819-2022
Class II · Moderate risk

Pge-2

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0029-10 D-0818-2022
Class II · Moderate risk

Pge-1

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0028-10 D-0817-2022
Class II · Moderate risk

Bimix-3

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0027-10 D-0815-2022
Class II · Moderate risk

Re-2

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0016-10 D-0814-2022
Class II · Moderate risk

Re-1

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0015-10 D-0813-2022
Class II · Moderate risk

Qm-4

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0020-10 D-0812-2022
Class II · Moderate risk

Qm-3

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0019-10 D-0811-2022
Class II · Moderate risk

St-2

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0012-10 D-0810-2022
Class II · Moderate risk

St-1

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0011-10 D-0809-2022
Class II · Moderate risk

Sb-6

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0025-10 D-0808-2022
Class II · Moderate risk

Sb-5

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0024-10 D-0807-2022
Class II · Moderate risk

Sb-4

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0023-10 D-0806-2022
Class II · Moderate risk

T-101

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0014-10 D-0805-2022
Class II · Moderate risk

T-106

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0013-05 D-0804-2022
Class II · Moderate risk

Nb-243

CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated

Terminated cGMP deviation Olympia Compounding Pharmacy dba Olympia Pharmacy NDC 73198-0009-10 D-0803-2022